[Retracted] Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway
- Authors:
- Published online on: March 31, 2025 https://doi.org/10.3892/mmr.2025.13508
- Article Number: 143
-
Copyright : © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
Mol Med Rep 17: [Related article:] 7163–7169, 2018; DOI: 10.3892/mmr.2018.8769
Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the Transwell migration and invasion assay data shown in Fig. 3E and F on p. 7166 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports. In view of the fact that the abovementioned data had already apparently been published previously, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.
